tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

OPRX Stock Latest News

OptimizeRx continues to expand strategic relationship with pharma client
The FlyOptimizeRx continues to expand strategic relationship with pharma client
2M ago
OPRX
OptimizeRx price target lowered to $14 from $17 at RBC Capital
PremiumThe Fly
OptimizeRx price target lowered to $14 from $17 at RBC Capital
3M ago
OPRX
OptimizeRx price target lowered to $11 from $15 at Barclays
PremiumThe Fly
OptimizeRx price target lowered to $11 from $15 at Barclays
3M ago
OPRX
OptimizeRx price target lowered to $15 from $17 at Lake Street
PremiumThe Fly
OptimizeRx price target lowered to $15 from $17 at Lake Street
3M ago
OPRX
OptimizeRx reports Q2 EPS 2c, consensus (6c)
PremiumThe Fly
OptimizeRx reports Q2 EPS 2c, consensus (6c)
3M ago
OPRX
OptimizeRx resumed with a Buy at B. Riley
PremiumThe FlyOptimizeRx resumed with a Buy at B. Riley
3M ago
OPRX
OptimizeRx delivers AI-guided privacy-compliant platform
Premium
The Fly
OptimizeRx delivers AI-guided privacy-compliant platform
3M ago
OPRX
OptimizeRx announces results on Dynamic Audience Activation Platform
Premium
The Fly
OptimizeRx announces results on Dynamic Audience Activation Platform
4M ago
OPRX
OptimizeRx publishes white paper on closing the health information gap
PremiumThe Fly
OptimizeRx publishes white paper on closing the health information gap
5M ago
OPRX
OptimizeRx Stockholders Approve Expansion and Elect Directors
PremiumCompany Announcements
OptimizeRx Stockholders Approve Expansion and Elect Directors
5M ago
8K
OPRX
OptimizeRx price target raised to $16 from $15 at JMP Securities
PremiumThe Fly
OptimizeRx price target raised to $16 from $15 at JMP Securities
6M ago
OPRX
OptimizeRx backs FY24 revenue view at least $100M, consensus $101.31M
PremiumThe Fly
OptimizeRx backs FY24 revenue view at least $100M, consensus $101.31M
6M ago
OPRX
OptimizeRx reports Q1 EPS (11c), consensus (13c)
PremiumThe FlyOptimizeRx reports Q1 EPS (11c), consensus (13c)
6M ago
OPRX
OptimizeRx sees Q1 revenue $18.5M-$19.2M, consensus $17.03M
Premium
The Fly
OptimizeRx sees Q1 revenue $18.5M-$19.2M, consensus $17.03M
6M ago
OPRX
Navigating New Horizons: Optimizerx Corporation’s Strategic Pivot Raises Financial Risk Flags
Premium
Company Announcements
Navigating New Horizons: Optimizerx Corporation’s Strategic Pivot Raises Financial Risk Flags
7M ago
OPRX
OptimizeRx sees FY24 revenue at least $100M, consensus $104.73M
PremiumThe Fly
OptimizeRx sees FY24 revenue at least $100M, consensus $104.73M
7M ago
OPRX
OptimizeRx reports Q4 EPS 26c, consensus 32c
PremiumThe Fly
OptimizeRx reports Q4 EPS 26c, consensus 32c
7M ago
OPRX
OptimizeRx’s preliminary Q4 results support bullish thesis, says Roth MKM
PremiumThe Fly
OptimizeRx’s preliminary Q4 results support bullish thesis, says Roth MKM
7M ago
OPRX
OptimizeRx initiated with an Outperform at JMP Securities
PremiumThe Fly
OptimizeRx initiated with an Outperform at JMP Securities
7M ago
OPRX
OptimizeRx cuts FY24 revenue view to at least $100M from at least $110M
PremiumThe FlyOptimizeRx cuts FY24 revenue view to at least $100M from at least $110M
8M ago
OPRX
OptimizeRx backs FY23 revenue view at least $68M-$70M, consensus $69.85M
Premium
The Fly
OptimizeRx backs FY23 revenue view at least $68M-$70M, consensus $69.85M
8M ago
OPRX
OPRX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
OPRX Upcoming Earnings Report: What to Expect?
8M ago
OPRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >